Stimulus hops, US stock futures rise on vaccine rollout –

Stimulus hops, US stock futures rise on vaccine rollout

US stock futures rose on optimism on Monday that negotiations for additional fiscal stimulus were moving forward and the rollout of Kovid-19 vaccines could help stem the epidemic.

Futures tied to the S&P 500 stood at 0.8%, indicating broad-market indices could gain after New York opens. Contracts related to the Nasdaq-100 index rose 0.6%.

US lawmakers indicated a growing desire to compromise on the most controversial issues in recent months by the passage of a fresh coronovirus-relief package. The leadership of both parties indicated that they could look to pass a narrow spending bill. Investors are betting that a deal will be done, and the additional spending will help increase the economic rebound.

Pfizer has packed Kovid-19 vaccines on trucks and has started deliveries in the US as the first vaccination begins Monday. The WSJ describes how America’s most urgent vaccination campaign has been going on in decades. Photo: Maurish Gush / Pool / Shutterstock

“In the US, it’s all about fiscal policy,” said Justin Ongquisi, Head of Retail Multiset Funds in Legal and General Investment Management. “Something is priced in the markets and believe it is going to happen.”

Pfizer began shipping trucks from the Michigan plant to the US for its Kovid-19 vaccine. Vaccination may begin as of Monday. It is optimistic that increasing levels of infection can be tested in the coming months, which will end the ban on social and business activities. The end of the lockdown will improve the outlook for companies whose operations have been disrupted by the epidemic this year.

The vaccine “gives you more certainty around the earnings numbers for 2021 and 2022 because there is less chance of lockdown,” Mr. Onyewucci said. “When you spend at a low earnings level, more companies start getting into trouble because there is no demand, and then you get this current economic fear.”

In Premarket Trading, shares of Alexion Pharmaceuticals ALXN 1.78%

It grew more than 30% after AstraZeneca agreed to buy the Boston-based company for $ 39 billion in cash and stock. AstraZeneca shares fell nearly 6% in London Trading.

Vaccination with a Kovid-19 vaccine from Pfizer and partner BioNTech may begin in the US on Monday.


Pascal Bonire / Zuma Press

Shares of vaccine manufacturers rose after Pfizer and partner BioNtech SE, authorized by the US Food and Drug AdministrationOf

Shot on Friday. Pfizer gained 1.4%, Modern 3% and Novavex gained over 2%.

Pluralit rose 5% after private-equity firm Vista Equity Partners agreed to buy the educational-software maker.

In bond markets, the yield on the 10-year US Treasury note ticked from 0.892% to 0.926% on Friday. Yields increase when bond prices fall.

Overseas, all-continental stocks Europe 600 rose about 1%.

The British pound rose 1.6% against the dollar and 1.2% against the euro. Investors expect the UK and European Union to strike a trade deal, when the two sides agree to continue negotiations after Sunday’s deadline. Officials said they are narrowing differences on some issues that have thwarted negotiations.

“The fact that the negotiations are continuing has left a spark of hope that the two sides want to compromise,” said Jane Foley, head of foreign exchange strategy at Rabbonk.

Trade in Asia ended on a mixed note. China’s Shanghai Composite Index moved up 0.7% and Japan’s Nikkei 225 gained 0.3%. Cospi of South Korea lost 0.3%.

Write Caitlin Ostroff at [email protected]

Copyright © 2020 Dow Jones & Company, Inc. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8


Leave a Reply

Your email address will not be published.